Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Methylprednisolone Sodium Succinate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,454Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hikma's Generic Methylprednisolone Sodium Succinate Receives Approval in the U.S.
    Hikma's Generic Methylprednisolone Sodium Succinate Receives Approval in the U.S.

    26 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203125

    FDA
    26 Sep 2022
    Share Share
    Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection
    Dr Reddy's launches generic Methylprednisolone Sodium Succinate for injection

    05 Apr 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-generic-methylprednisolone-sodium-succinate-for-injection-in-us/articleshow/90661596.cms

    ECONOMIC TIMES
    05 Apr 2022
    Share Share
    Enforcement Report - Week of January 29, 2020
    Enforcement Report - Week of January 29, 2020

    29 Jan 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-29-2020-1580279088.pdf

    FDA
    29 Jan 2020
    Share Share
    Enforcement Report - Week of March 21, 2018
    Enforcement Report - Week of March 21, 2018

    21 Mar 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-21-2018-1521610042.pdf

    FDA
    21 Mar 2018
    Share Share
    Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP
    Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP

    07 Mar 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-of-methylprednisolone-sodium-succinate-for-injection-usp-1520501453.pdf

    FDA
    07 Mar 2018
    Share Share
    Sagent Pharma Issues Voluntary Recall of Methylprednisolone Sodium Succinate
    Sagent Pharma Issues Voluntary Recall of Methylprednisolone Sodium Succinate

    05 Mar 2018

    // Sagent Pharmaceuticals, Inc.  PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-of-methylprednisolone-sodium-succinate-for-injection-usp-40mg-125mg-and-1g-due-to-high-out-of-specification-impurity-results-300608542.html

    Sagent Pharmaceuticals, Inc.  PR NEWSWIRE
    05 Mar 2018
    Share Share